1. Home
  2. INLF vs EVGN Comparison

INLF vs EVGN Comparison

Compare INLF & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INLF

INLIF LIMITED

HOLD

Current Price

$0.61

Market Cap

10.6M

Sector

Industrials

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$1.10

Market Cap

10.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLF
EVGN
Founded
2016
1999
Country
China
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Agricultural Chemicals
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
10.9M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
INLF
EVGN
Price
$0.61
$1.10
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
538.5K
48.2K
Earning Date
09-29-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,332,282.00
$8,016,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.35
P/E Ratio
N/A
N/A
Revenue Growth
33.11
7.19
52 Week Low
$0.54
$0.95
52 Week High
$21.00
$2.42

Technical Indicators

Market Signals
Indicator
INLF
EVGN
Relative Strength Index (RSI) 47.07 45.46
Support Level $0.54 $1.03
Resistance Level $0.74 $1.14
Average True Range (ATR) 0.05 0.07
MACD 0.01 -0.00
Stochastic Oscillator 51.01 42.31

Price Performance

Historical Comparison
INLF
EVGN

About INLF INLIF LIMITED

INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

Share on Social Networks: